BMO Capital lowered the firm’s price target on Intellia Therapeutics (NTLA) to $50 from $70 and keeps an Outperform rating on the shares. The company’s AATD discontinuation is the right decision and ...

Analyst Terence Flynn of Morgan Stanley maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report), retaining the price target ...

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) had its price target dropped by equities research analysts at BMO ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Winds Strengthen in L.A. as Wildfire Death Toll Rises to 16 At a Palisades mobile home park, middle-class dreams lie in ruins. Watch Duty, a wildfire-tracking app, provides a lifeline in Los ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...

Cruise Hive has you covered with yours cruise news round-up from the past week, including stories on NCL, Carnival, Princess Cruises, Outbreaks and more. The inaugural visit of Viking’s newest ...

Researchers have uncovered new details about a 3,000-year-old fortress in the Caucasus Mountains, using drone technology to explore the ancient settlement. The study, led by Dr. Nathaniel Erb-Satullo ...